Press Release

Printer Friendly Version View printer-friendly version
<< Back
POZEN Announces April 28 Webcast of First Quarter 2005 Results

CHAPEL HILL, N.C.--(BUSINESS WIRE)--April 14, 2005--POZEN Inc. (NASDAQ:POZN), announced today that it will release first quarter results on April 28, 2005, before the market opens.

The announcement will be followed by a live webcast at 11:00 a.m. Eastern Time of a discussion by POZEN management of the financial and business results. The webcast can be accessed on POZEN's website at www.pozen.com and will be archived and available for replay. The first quarter financial release can be accessed in the News section of POZEN's website.

POZEN is a pharmaceutical company committed to developing therapeutic advancements for diseases with unmet medical needs where it can improve efficacy, safety, and/or patient convenience. Since its inception, POZEN has focused its efforts primarily on the development of pharmaceutical products for the treatment of migraine. POZEN is also exploring the development of product candidates in other pain-related therapeutic areas. POZEN has development and commercial alliances with GlaxoSmithKline, Xcel Pharmaceuticals, and Nycomed. The company's common stock is traded on The Nasdaq Stock Market under the symbol "POZN". For detailed company information, including copies of this and other press releases, see POZEN's website: www.pozen.com.


    CONTACT: POZEN Inc.
             Bill Hodges, 919-913-1030
             Fran Barsky, 919-913-1044

    SOURCE: POZEN Inc.

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.